|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,944.00 INR | +0.10% |
|
+0.21% | +13.04% |
| 08-05 | CRISIL Keeps AAA Rating on Sun Pharmaceutical's Bank Facilities | MT |
| 07-31 | Sun Pharmaceutical Industries Limited, Q1 2027 Earnings Call, Jul 31, 2026 |
| Market Cap | 4,660B 48.85B 42.34B 39.63B 36.16B 68.05B 69.19B 465B 182B 2,332B 183B 179B 7,781B | P/E 2027 * |
35.8x | P/E 2028 * | 30.3x |
|---|---|---|---|---|---|
| Enterprise Value | 4,380B 45.93B 39.8B 37.26B 34B 63.98B 65.05B 437B 171B 2,193B 172B 169B 7,315B | EV / Sales 2027 * |
6.73x | EV / Sales 2028 * | 5.92x |
| Free-Float |
44.39% | Yield 2027 * |
0.88% | Yield 2028 * | 1.02% |
Last Transcript: Sun Pharmaceutical Industries Ltd.
| 1 day | +0.10% | ||
| 1 week | +0.21% | ||
| Current month | -2.34% | ||
| 1 month | +1.18% | ||
| 3 months | +5.33% | ||
| 6 months | +13.36% | ||
| Current year | +13.04% |
| 1 week | 1,925.1 |  | 1,965.9 |
| 1 month | 1,910 | | 2,046.9 |
| Current year | 1,583.7 | | 2,046.9 |
| 1 year | 1,548 | | 2,046.9 |
| 3 years | 1,068.35 | | 2,046.9 |
| 5 years | 733.7 | | 2,046.9 |
| 10 years | 312 | | 2,046.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 01/09/2025 | |
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Director of Finance/CFO | 58 | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
| Director/Board Member | 59 | 01/09/2025 | |
| Director/Board Member | 73 | 25/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.10% | +0.21% | +19.84% | +71.39% | 48.85B | |
| -2.47% | +3.77% | +55.63% | +121.20% | 41.43B | |
| +1.18% | +7.48% | +26.09% | +87.80% | 12.46B | |
| 0.00% | +0.29% | -3.85% | +18.40% | 12.39B | |
| +1.15% | -0.38% | +30.98% | +136.36% | 9.08B | |
| -0.15% | +7.27% | +24.31% | +39.68% | 7.53B | |
| -0.12% | +5.00% | +40.26% | -12.95% | 7.14B | |
| +0.62% | +1.37% | +11.26% | +187.09% | 6.73B | |
| -1.22% | +4.46% | -25.04% | +29.64% | 5.88B | |
| +0.97% | +3.01% | +31.28% | +103.67% | 4.59B | |
| Average | -0.02% | +3.14% | +21.08% | +78.23% | 15.61B | |
| Weighted average by Cap. | -0.48% | +3.34% | +28.03% | +84.48% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 651B 6.82B 5.91B 5.54B 5.05B 9.51B 9.67B 64.92B 25.44B 326B 25.62B 25.07B 1,087B | 729B 7.64B 6.62B 6.2B 5.66B 10.64B 10.82B 72.68B 28.48B 365B 28.69B 28.06B 1,217B |
| Net income | 130B 1.36B 1.18B 1.11B 1.01B 1.9B 1.93B 12.98B 5.09B 65.15B 5.12B 5.01B 217B | 154B 1.62B 1.4B 1.31B 1.2B 2.25B 2.29B 15.38B 6.03B 77.18B 6.07B 5.94B 257B |
| Net Debt | -279B -2.93B -2.54B -2.37B -2.17B -4.08B -4.14B -27.83B -10.9B -140B -10.98B -10.75B -466B | -349B -3.66B -3.17B -2.97B -2.71B -5.1B -5.19B -34.82B -13.64B -175B -13.75B -13.45B -583B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | ₹1,944.00 | +0.10% | 1,536,383 |
| 11/08/26 | ₹1,942.00 | -0.12% | 2,125,972 |
| 10/08/26 | ₹1,944.40 | -0.03% | 1,726,946 |
| 07/08/26 | ₹1,945.00 | -0.31% | 2,425,268 |
| 06/08/26 | ₹1,951.00 | +0.57% | 1,864,891 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUNPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
